Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 15, 2014OncotargetOpen Access

Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57

View Full Paper
Ask AI
Bookmark
Share

Authors

XZXuekai ZhuChina State Shipbuilding (China)SPShruthi PrasadUniversity of FreiburgSGSimone GaedickeUniversity of Freiburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhu et al. (2014) studied this question.

synapsesocial.com/papers/69d8a210183921ebcaae304ahttps://doi.org/10.18632/oncotarget.2767
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The evolving landscape of glioblastoma stem cells2013 · 75 citations
  2. 2Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells2010 · 312 citations
  3. 3Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype2012 · 23 citations
  4. 4Eradication of melanomas by targeted elimination of a minor subset of tumor cells2011 · 123 citations
  5. 5Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy2011 · 1,538 citations